Journal Watch October 2024

Here are some of the most recent publications from top medical journals as of October 2024. Contact me for custom reports and literature review.

1. SGLT-2 Inhibitors for Chronic Kidney Disease (BMJ)

A recent review in BMJ examines the impact of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on survival and cardiovascular outcomes in patients with chronic kidney disease (CKD). This class of drugs, originally developed for diabetes, has shown significant benefits for slowing kidney disease progression and improving outcomes in CKD patients. More HERE

2. COVID-19 Vaccine Effectiveness in Older Europeans (JAMA)

A study published in JAMA focuses on the effectiveness of COVID-19 vaccines in preventing symptomatic infections among Europeans aged 60 and older during the 2022-2023 season. The findings are essential for understanding vaccine efficacy in high-risk populations and could inform future vaccination strategies. More HERE

3. Cardiovascular Risk Biomarkers in Women (NEJM Journal Watch)

A publication in NEJM Journal Watch* discusses long-term cardiovascular risks in women, focusing on biomarkers like C-reactive protein, LDL cholesterol, and lipoprotein(a). This study highlights how these factors independently predict major cardiovascular events in women, contributing to personalized risk assessment and prevention strategies. More HERE

4. Critical Care Trials Trends (NEJM & JAMA)

A recent analysis compared the number of critical care clinical trials published in leading journals like NEJM and JAMA from 1970 to 2022. The study found that both journals have significantly increased the publication of critical care trials in the past decade, reflecting heightened interest in this area of medicine. More HERE